[1]
«Improving the Drug Bioavailability Property of Myricetin through a Structural Monosubstitution Modification Approach: an In-Silico Pharmacokinetics Study», AJBR, vol. 22, núm. 3, p. 347–352, des. 2019, Consulta: 5 abril 2026. [En línia]. Disponible a: https://www.ojshostng.com/index.php/ajbr/article/view/1335